IE 11 is a very old Browser and it`s not supported on this site

5. Board of Directors: Compensation, loans and stock ownership

5.1 Compensation

CHF

Veit de Maddalena 3)

Urs Schenker

Katrin Wehr-Seiter

Barbara Angehrn Pavik

Total

01.01.–31.12.2025

Fixed compensation

232 917

178 750

163 750

165 833

741 250

– in cash

179 167

131 250

123 000

122 583

556 000

– in shares 1)

53 750

47 500

40 750

43 250

185 250

Non-monetary benefit from voluntary stock purchase programs 2)

16 179

16 179

16 179

48 537

Social insurance contributions

10 780

12 655

23 435

Total compensation

232 917

205 709

179 929

194 667

813 222

1) Compulsory employee contributions to social insurance plans on the amounts above were settled in cash, not in the form of shares.
2) This is the amount of the monetary benefit which reflects the difference between the discounted purchase price and the 10-day VWAP for the effective share allocation.

3) The compensation received by the Executive Chairman of the Board of Directors, Veit de Maddalena, in his function as CEO is disclosed in section 6.2 under «Group Executive Board: Compensation, Loans and Shareholdings.”

CHF

Veit de Maddalena

Urs Schenker

Katrin Wehr-Seiter

Barbara Angehrn Pavik

Total

01.01.–31.12.2024

Fixed compensation

258 000

163 000

168 000

153 000

742 000

– in cash

193 500

122 250

126 000

114 750

556 500

– in shares 1)

64 500

40 750

42 000

38 250

185 500

Non-monetary benefit from voluntary stock purchase programs 2)

7 771

7 771

6 217

7 771

29 530

Social insurance contributions

105

9 309

11 369

20 783

Total compensation

265 876

180 080

174 217

172 140

792 313

1) Compulsory employee contributions to social insurance plans on the amounts above were settled in cash, not in the form of shares.
2) This is the amount of the monetary benefit which reflects the difference between the discounted purchase price and the 10-day VWAP for the effective share allocation.

The fixed compensation must be approved by the Annual General Meeting for the term of office extending to the next scheduled Annual General Meeting in accordance with Art. 8 para. 1, section 1 of the Articles of Association. For the period from the 2024 AGM to the 2025 AGM, fixed compensation (including the monetary benefit from voluntary employee stock ownership plans and compulsory employer contributions to social insurance plans) of CHF 880 000 (2023/2024: CHF 880 000) was approved. The actual amount paid (including the monetary benefit from voluntary employee stock ownership plans and compulsory employer contributions to social insurance plans) for the aforementioned period amounted to CHF 812 252 (2023/2024: CHF 791 635). For the current period from 2025 AGM to the 2026 AGM, fixed compensation (including the monetary benefit from voluntary employee stock ownership plans and compulsory employer contributions to social insurance plans) of CHF 828 000 was approved.

The resolutions of the Annual General Meeting regarding the fixed remuneration for the Board of Directors for the period from the Annual General Meeting 2024 to the Annual General Meeting 2025 were therefore complied with.

In 2025 and 2024, the Board of Directors authorized a voluntary employee stock ownership plan. The members of the Board of Directors were allocated to purchase 15 000 shares (2024: 9 500 shares) of the Company from the given pool at a discounted price of CHF 5.75 per share (2024: CHF 12.75 per share). This represented a discount of approximately 25% on the quarterly VWAP prior to the date the purchase right was granted. The difference between the 10-day VWAP on the date the shares are actually transferred and the purchase price corresponds to the monetary benefit. This cash compensation is subject to the approval of shareholders at the Annual General Meeting. The shares were blocked for three years from the date of transfer.

The compensation of the Board of Directors has not changed significantly compared to the previous year. The changes shown are related to the valuation of the shares allocated or acquired under the voluntary participation programs.

In fiscal year 2025, no compensation was paid (2024: none) to related parties of members of the Board of Directors on conditions other than the customary market conditions.

No compensation was paid to former members of the Board of Directors after their resignation in the 2025 financial year, nor in the preceding year.

5.2 Loans and credits

As of the end of 2025 and 2024, no loans and no credits had been granted either to members of the Board of Directors or to former members of the Board of Directors or any related parties.

5.3 Holdings of shares in the Company

The number of shares in the Company held by the members of the Board of Directors at the end of 2025 and 2024 were as follows:

Number of shares

31.12.2025

31.12.2024

Veit de Maddalena, Executive Chairman 1)

292 468

275 189

Urs Schenker, Member

58 160

32 068

Katrin Wehr-Seiter, Member

35 683

25 164

Barbara Angehrn Pavik, Member

20 593

10 111

1) The table above includes all shareholdings (across all functions).

5.4 Activities in other companies

Veit de Maddalena, Executive Chairman

BG (Suisse) Private Bank SA

Switzerland

Chairman of the Board of Directors

Private

de Maddalena & Co. AG

Switzerland

Chairman of the Board of Directors

Private

Loft Dynamics AG

Switzerland

Chairman of the Board of Directors

Private

Marigin AG

Switzerland

Member of the Board of Directors

Private

Candor Board Services GmbH

Switzerland

Partner

Private

Urs Schenker, Member

EBV Immobilien AG

Switzerland

Chairman of the Board of Directors

Private

Erlen Capital Management AG

Switzerland

Chairman of the Board of Directors

Private

Geschäftshaus City AG Dübendorf

Switzerland

Chairman of the Board of Directors

Private

Invico Asset Management AG

Switzerland

Chairman of the Board of Directors

Private

Swisa Holding AG

Switzerland

Chairman of the Board of Directors

Private

Arctos Capital AG

Switzerland

Member of the Board of Directors

Private

Hansa Aktiengesellschaft

Switzerland

Member of the Board of Directors

Private

Indicium Technologies AG

Switzerland

Member of the Board of Directors

Private

Ornak AG

Switzerland

Member of the Board of Directors

Private

Ufenau Capital Partners AG

Switzerland

Member of the Board of Directors

Private

Personalvorsorgestiftung der Pfizer AG in Liquidation

Switzerland

Chairman of the Board of Trustees

Private

Katrin Wehr-Seiter, Member

SES S.A.

Luxembourg

Member of the Board of Directors, member of the Audit & Risk Committee, member of the Remuneration Committee

Listed

BIP Capital Partners 1)

Luxembourg

Member of the Board of Directors

Private

BIP (GP) Sarl 1)

Luxembourg

Member of the Board of Managers

Private

BIP General Partner 1)

Luxembourg

Member of the Board of Managers

Private

The Simpleshow Company S.A. 2)

Luxembourg

Member of the Board of Directors

Private

Mercateo Deutschland AG 3)

Germany

Member of the Supervisory Board

Private

Unite Holding SE 3)

Germany

Member of the Supervisory Board

Private

Unite Network SE 3)

Germany

Member of the Supervisory Board

Private

Wellcosan Beteiligungs GmbH

Germany

Member of the Advisory Board

Private

1) BIP (GP) Sarl (with wholly owned subsidiary Coquelicots Holdings Sarl acting as holding vehicle) and BIP General Partner Sarl (with wholly owned subsidiaries Bleuets Holdings Sarl and Marguerites Holdings Sarl acting as holding vehicles) are wholly owned subsidiaries of BIP Capital Partners.

2) 100% subsidiary of D-ID Ltd. after merger

3) Unite Network SE and Mercateo Deutschland AG are wholly owned subsidiaries of Unite Holding SE.

Barbara Angehrn Pavik, Member

medmix AG

Switzerland

Member of the Board of Directors, member of the Nomination & Compensation Committee

Listed

Numab Therapeutics AG

Switzerland

Member of the Board of Directors

Private

Stepstone Pharma GmbH

Switzerland

Partner

Private